Header image

HIV&AIDS: Symposium - Theme B - s100 prescriber session - Changing landscapes in Therapy

Tracks
1
Wednesday, November 8, 2017
11:30 AM - 1:00 PM
Royal Theatre

Details

This session will focus on issues pertinent to current prescribers including drug-drug interactions with new antiretrovirals, update on 2 drug regimens and strategies to minimise drug toxicity. Learning Objectives: Participants will gain knowledge on drug-drug interactions with newer agents such as cobicistat and tenofovir alefenamide, be updated on the current status of 2 drug antiretroviral regimens, identify situations where it is better to stop an antiretroviral causing a toxicity or continue the antiretroviral but treat the toxicity with an other method or drug, and be updated on polypharmacy for people with HIV from a large Australian cohort.


Speaker

Attendee506

Drug Drug interactions – When is cobicistat not ritonavir, when is TAF not TDF

11:30 AM - 11:52 AM

Abstract

Speaker Presentation

Audio Recording

Biography

Attendee1021

When is 2 drugs better than 3

11:52 AM - 12:14 PM

Speaker Presentation

Audio Recording

Biography

Attendee119

Polypharmacy of Concomitant Medications in HIV-Infected Australian Adults is Common, and Associated with Adverse Effects

12:36 PM - 12:47 PM

Abstract

Speaker Presentation

Biography

Attendee119

Failure of Antiretroviral Therapy (ART) In Australian Adults Is Mainly Due To ART Toxicity

12:47 PM - 12:58 PM

Abstract

Speaker Presentation

Audio Recording

Biography

Attendee1236

HIV Comorbidities: Treat, Switch ART, or Both?

12:14 PM - 12:36 PM

Speaker Presentation

Audio Recording

Biography

loading